| 345.24 Delayed Data As of Sep 20 |  +5.51 / +1.62%Today’s Change | 220.05 Today|||52-Week Range 347.27 | +48.67% Year-to-Date |
| Previous close | 339.73 |
| Today’s open | 342.16 |
| Day’s range | 342.16 - 347.27 |
| Volume | 415,943 |
| Average volume (3 months) | 186,398 |
| Market cap | $8.5B |
| Earnings growth (last year) | +197.26% |
| Earnings growth (this year) | +22.00% |
| Earnings growth (next 5 years) | +18.88% |
| Revenue growth (last year) | +5.98% |
| P/E ratio | 11.5 |
| Price/Sales | 3.07 |
| Price/Book | 2.56 |
| Today’s change | Today’s % change | |
|---|---|---|
| QGENQiagen NV | -0.15 | -0.44% |
| PKIPerkinElmer Inc | +0.46 | +0.53% |
| BRKRBruker Corp | +0.01 | +0.02% |
| DHRPRADanaher Corp | +4.59 | +0.39% |
| Next reporting date | November 7, 2019 |
| EPS forecast (this quarter) | $1.41 |
| Annual revenue (last year) | $2.3B |
| Annual profit (last year) | $365.6M |
| Net profit margin | 15.97% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Norman D. Schwartz |
Chief Operating Officer & Executive Vice President Andrew J. Last |
Corporate headquarters Hercules, California |
